Both in Surgical Instruments
Heartbeam vs Nephros
Over the past year BEAT returned −66.2% and NEPH returned −43.4%; their daily moves had a correlation of -0.05.
BEAT −66.2% NEPH −43.4%Growth of $1, one year, split-adjusted
| Metric | BEAT | NEPH |
|---|---|---|
| Price | $0.5348 | $3.25 |
| Market cap | $30.1M | $35.3M |
| Today | +0.56% | +2.52% |
| 1 month | +45.9% | −12.4% |
| 6 months | −37.7% | +2.8% |
| Year to date | −77.7% | −33.4% |
| 1 year | −66.2% | −43.4% |
| Revenue growth (YoY) | — | +36.2% |
| Gross margin | — | 66.9% |
| Net margin | — | 19.9% |
| P/E (TTM) | — | 20.3× |
| Price / sales | — | 1.7× |
| Net cash | $8.7M | $4.7M |
| Dividend yield | — | — |
| Volatility (60d) | 132.0% | 79.9% |
| Short % of float | 6.0% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).